Instituto Valencia de Oncologia

Site:	Instituto Valencia de Oncologia
Address:
City:	Valencia
State:
Zip:	46009
Country:	Spain

Phase	Trial	Trial Status	Site Status	Drug	NCT#
2	Single Agent Regorafenib in First-line for Metastatic/Unresectable KIT/PDGFR Wild Type GIST (REGISTRI)	Completed	Active	Regorafenib (SDH)	NCT02638766